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1  | INTRODUC TION
During the first years of life, airway infections commonly involve coughing, 
but the cough normally ceases within two to three weeks.1-3 Some chil-
dren experience recurrent episodes with cough or chronic cough, some-
times leading to the suspicion of an underlying disease. Chronic cough is 
defined as a cough that persists for more than four or eight weeks,4-10 and 
in preschool children, the cough is mainly wet or productive due to mucus 
secretion.4 An untreated chronic cough may last for months and lead to 
impaired sleeping, poor feeding, sick leave and reduced quality of life for 
the children and families affected.4,5,7,10,11 Most children with recurrent 
episodic or chronic wet cough probably have a good prognosis, but for 
some children, the cough represents the first sign of chronic suppurative 
lung disease, which is important to diagnose and treat early.5,10,12
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Abstract
Aim: We aimed to study the natural course of recurrent episodic and chronic wet 
cough in preschool children, the proportion and age of resolution, and risk factors for 
persistent symptoms.
Methods: Parents of children with recurrent or chronic wet cough who had attended 
the outpatient clinic before the age of three years during 2010-2013 at Stavanger 
University Hospital, Norway, answered a questionnaire regarding clinical symptoms 
and current medication at a follow-up in 2017-2018.
Results: We invited 840 children to participate, and parents consented for 348 
(41.4%) of the children. At the first outpatient visit, 171 children (58.8%) had recur-
rent episodic and 120 (41.2%) had chronic wet cough. At follow-up at a median age 
of 82 months, 57.0% in both groups were symptom-free, and 9.4% with episodic 
cough and 13.3% with chronic cough had more than mild symptoms. During the last 
12 months prior to the survey, 27.2% with episodic cough and 18.6% with chronic 
cough had used inhaled corticosteroids.
Conclusion: Half of the preschool children with recurrent episodic or chronic wet 
cough outgrew their symptoms by the median age of seven years, but one in four still 
used inhaled corticosteroids.
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Episodic or chronic wet cough is a common reason for consulting 
a primary care physician and referral to a specialist. Handling recur-
rent or chronic cough is challenging, even in a specialist unit. Children 
with chronic wet cough may be misdiagnosed with asthma, leading 
to overdiagnosis and overtreatment with potential side effects.13-15 
The few available objective tests, such as bronchoscopy and thoracic 
CT scan, are limited by capacity and burden of the procedure for the 
child. Evaluation is therefore mainly based on the medical history 
and the clinical examination.16
Studies have suggested that protracted bacterial bronchitis (PBB) 
with bacterial colonisation in lower airways is the most common 
reason for chronic wet cough in young children, with antibiotics for 
two to four weeks as the recommended treatment.4,16,17 However, 
studies of children with chronic wet cough are largely based on se-
lected patients recruited from tertiary centres.4 To date, few studies 
have evaluated the natural course and identified risk factors for a 
prolonged course or an underlying chronic disease in children with 
recurrent episodic or chronic wet cough, including PBB.3,4,10
In clinical practice, separating chronic wet cough from long-last-
ing recurrent episodes of wet cough by history is challenging. 
Furthermore, concurrent bronchopulmonary obstruction or wheez-
ing is common, leading to increased suspicion of asthma as the un-
derlying cause. Studies on the natural history of wet cough should 
therefore include these issues. Our aims were to study the long-term 
course of young children with recurrent episodic and chronic wet 
cough, find the proportion and age of spontaneous resolution, and 
to identify possible risk factors for persistence of symptoms.
2  | METHODS
2.1 | Study site and subjects
The study subjects were recruited from the paediatric outpatient 
clinic at Stavanger University Hospital in Norway, which covers a 
population of approximately 15 000 children under three years of 
age and have a yearly birth rate of approximately 4500. The hospital 
has the only paediatric ward and outpatient clinic covering this area 
and all children requiring specialist consultations are therefore re-
ferred to our hospital.
The recruitment of participants for this retrospective study is 
shown in Figure 1. In the first step, we reviewed the medical records 
of children under the age of three years who had at least one visit 
to the children's pulmonary outpatient clinic at Stavanger University 
Hospital from January 1, 2010, to December 31, 2014, with the 
following ICD-10 diagnoses; J40-J47 chronic lower respiratory dis-
eases, Q30-Q34 congenital malformations of the respiratory sys-
tem or R05 cough. Children were eligible for inclusion if they had 
recurrent episodic or chronic wet cough, with or without episodes of 
wheezing, with a total duration exceeding four weeks. Children were 
excluded if they were born at less than 32 weeks of gestation or had 
been diagnosed with a heart, lung or neuromuscular disease or any 
other chronic disease potentially affecting the lungs at the time of 
referral. Also, children with a known diagnosis of asthma or a history 
of mainly recurrent episodes with wheezing without wet cough were 
not included. If the children were found eligible for inclusion, their 
parents were invited by letter to participate. Parents who did not 
respond were sent one reminder by post, and finally one reminder 
with the possibility to respond electronically.
The study was approved by the Regional Committee for Medical 
Research Ethics in Northern Norway. Signed statements of informed 
consent were obtained from the parents.
Key notes
• Episodic or chronic wet cough is common in young chil-
dren, but the long-term prognosis is not known.
• We studied the persistence of symptoms and medica-
tion in outpatient children under three years of age with 
episodic or chronic wet cough.
• Half of the preschool children with recurrent episodic or 
chronic wet cough outgrew their symptoms by the me-
dian age of seven years, but one in four still used inhaled 
corticosteroids.
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2.2 | Data collection
After consenting to participate, the parents consecutively answered 
a questionnaire about the status of the child at follow-up. They re-
ported airway symptoms during the last six months by answering 
the question: ‘Has your child had symptoms similar to those evalu-
ated at the outpatient clinic?’ If applicable, the parents were asked 
if the child had had coughing or wheezing, and if they considered 
the severity of the symptoms to be mild or severe. Furthermore, 
they were asked if the child had been using antibiotics or any 
asthma medications specified as any inhaled corticosteroid (ICS), 
inhaled short-acting beta-2 agonist or oral leukotrienantagonists 
during the last 12 months. If the symptoms had ceased, the parents 
reported the year and month for resolution of symptoms.
For those who consented, further data regarding previous ill-
nesses, family history, clinical findings and treatment prescribed 
were collected retrospectively by a review of the medical records 
(Figure 1). We included information from the first outpatient visit 
and all subsequent outpatient visits to our department, until the 
patient was no longer under follow-up. We recorded information 
on the children's gestational age and number of siblings, if they 
had pets at home or a family history of asthma and atopy and if 
they had ever been exposed to household smoking. We also re-
corded the age at debut of airway symptoms and if the main symp-
tom at the outpatient clinic consultation was wheezing episodes 
and/or chronic wet cough or stridor. A history of previous hospi-
talisation for airway disease or atopic dermatitis was registered. 
The results from examinations found indicated by a physician after 
clinical evaluation at the first or later outpatient visits were re-
corded, including lung function tests, chest X-rays and tests for 
atopic sensitisation by skin prick test or specific IgE. Finally, we 
recorded information about treatment started at the outpatient 
clinic including use of antibiotics, short-acting beta-2 agonist, use 
of ICS, inhalation with isotonic saline, chest physiotherapy and use 
of intermittent continuous positive airway pressure (CPAP) or a 
positive expiratory pressure (PEP) mask. Variables were catego-
rised as yes or no, except for the continuous variables including 
age, number of siblings and lung function.
Children who initially were considered eligible for inclusion were 
excluded if they after review of the medical records met at least one 
exclusion criteria or failed to meet the inclusion criteria (Figure 1).
2.3 | Definitions and measurements
Based on the history at the first outpatient visit, children were 
categorised into two groups. Children with recurrent episodic wet 
cough had more episodes with wet cough lasting more or less than 
four weeks each, but with a clear history of symptom-free intervals 
between episodes. Children with chronic wet cough had wet cough 
lasting for more than four weeks continuously from the start of 
symptoms to the first outpatient visit.
A positive chest X-ray was defined as any consolidation or at-
electasis at any time. Atopic sensitisation was defined as at least 
one positive skin prick test or specific IgE above 0.35 KU/L ever 
for any tested allergen. The lung function was measured at the first 
outpatient visit by tidal breathing flow-volume loops with a paedi-
atric pulmonary testing system (Exhalyzer, Ecomedics, Duernten, 
Switzerland) and reported as the ratio of time to reach peak tidal 
expiratory flow to total expiratory time (tPTEF/tE).
2.4 | Statistics
Data were expressed as proportions or medians and interquar-
tile ranges. Group comparisons were performed with Pearson's 





N (%) P valuesa 
All children 291 171/291 (58.8) 120/291 (41.2)  
Boys 175/291 (60.1) 108/171 (63.2) 67/120 (55.8) .209
Prematurity; 32-37 wk 
of gestation
20/203 (9.9) 15/113 (13.3) 5/90 (5.6) .067
Parental asthma or 
atopy
174/248 (70.2) 108/148 (73.0) 66/100 (66.0) .239
Siblings with asthma or 
atopy
75/153 (49.0) 43/86 (50.0) 32/67 (47.8) .783
Household smoking 28/111 (25.2) 12/61 (19.7) 16/50 (32.0) .137
Pets at home 42/94 (44.7) 26/56 (46.4) 16/38 (42.1) .679
Atopic dermatitis ever 86/226 (38.1) 57/140 (40.7) 29/86 (33.7) .293
Previous hospitalisation 
for airway infection
78/291 (26.8) 51/171 (29.8) 27/120 (22.5) .165
Note: The denominator represents the number of participants with available data.
aP values from Pearson's chi-square test. 
TA B L E  1   Basic characteristics of 291 
children under three years of age with 
recurrent episodic or chronic wet cough 
referred to a paediatric outpatient clinic
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chi-square test for dichotomous variables or Mann-Whitney U test 
for continuous variables. P for trend for ordinal variables with more 
than two categories was analysed by the linear-by-linear association 
test. Logistic regression analyses were performed to explore the as-
sociations between various risk factors and persistent symptoms at 
follow-up.
The significance level was set to 0.05 for all tests. Analyses were 
carried out using SPSS version 24.0 (IBM Corp. Armonk, New York, 
USA).
3  | RESULTS
After the first review of medical records, 840 children were found 
eligible for inclusion and their parents were invited to participate 
in the study. Informed consent was obtained from the parents of 
348 (41.4%) children. Of these, 57 children were excluded after the 
second review of the medical records, two children due to prematu-
rity and 55 children due to wheezing episodes as the main symptom 
for referral (Figure 1). Of the remaining 291 children, 171 (58.8%) 
had recurrent episodic wet cough and 120 (41.2%) had chronic wet 
cough before the first outpatient visit.
The basic characteristics of all children are given in Table 1. No differ-
ences regarding gender, family history of asthma and atopy, household 
smoking, pets at home or ever atopic dermatitis were found between chil-
dren with recurrent episodic cough and children with chronic wet cough.
The clinical characteristics, results of examinations and treat-
ment started at the first or subsequent outpatient visits are given 
in Table 2. Children with chronic wet cough were younger than 
children with recurrent episodic cough, both at the debut of symp-
toms, at the first outpatient clinic visit and at follow-up. The me-
dian duration of wet cough before the first visit was 9 months in 
children with a recurrent episodic cough and 8 months in children 
with a chronic cough. More children with recurrent episodic than 
chronic wet cough also had a history of wheezing episodes. More 
children with chronic wet cough were given antibiotics, inhaled 
isotonic saline, CPAP or chest physiotherapy than children with 
recurrent episodic wet cough.
3.1 | Follow-up—resolution of symptoms
At follow-up, parents reported by questionnaire that 57.0% of the 
included children had no symptoms, 32.0% had mild symptoms and 
TA B L E  2   Clinical characteristics for 291 children under three years of age with recurrent episodic or chronic wet cough referred to a 
paediatric outpatient clinic




cough N (%) P valuesa 
All children 291 171/291 (58.8) 120/291 (41.2)  
Age at debut of symptoms; months; median (quartiles) 291 10 (4,13) 6 (3,12) .015
Age at first visit; months; median (quartiles) 291 22 (15,28) 16 (9,26) <.001
Duration of symptoms from debut to first visit; months; median 
(quartiles)
291 9 (5,16) 8 (4,12) .005
History of wheezing episodes 173/291 (59.5) 120/171 (70.2) 53/120 (44.2) <.001
Consolidation/atelectasis on chest X-ray 88/239 (36.8) 49/134 (36.6) 39/105 (37.1) .927
Lung function, tPTEF/tE-ratiob ; %;median (quartiles) 232/291 (79.7) 36 (27, 45) 37 (27, 44) .683
Atopy 42/62 (67.7) 32/46 (69.6) 10/16 (62.5) .603
Treatment prescribed or continued at outpatient visits
No treatment 64/291 (22.0) 41/171 (24.0) 23/120 (19.2) .329
Antibiotics 61/282 (21.6) 22/165 (13.3) 39/117 (33.3) <.001
Beta-2 agonist 172/283 (60.8) 107/168 (63.7) 65/115 (56.5) .225
ICS 136/286 (47.6) 88/170 (51.8) 48/116 (41.4) .084
Inhalation of isotonic saline 49/287 (17.1) 22/169 (13.0) 27/118 (22.9) .029
Chest physiotherapy 16/287 (5.6) 5/170 (2.9) 11/117 (9.4) .019
CPAP 9/287 (3.1) 1/170 (0.6) 8/117 (6.8) .003
Note: Continuous variables were reported as medians and quartiles, dichotomous variables were reported as number and %.The denominator 
represents the number with available data.
Abbreviations: Beta-2 agonist, inhaled short-acting beta-2 agonist; CPAP, continuous positive airway pressure; ICS, inhaled corticosteroids in any 
combination.
aP values from Pearson's chi-square test for dichotomous variables or Mann-Whitney U test for continuous variables. Bold values represent P values 
under the significance level set to 0.05. 
bLung function was measured by tidal breathing and was reported as the ratio of time to reach peak tidal expiratory flow to total expiratory time 
(tPTEF/tE). 
     |  5SØRENSEN Et al.
11.0% had severe symptoms during the last six months before filling out 
the questionnaire (Table 3). In children without symptoms at follow-up, 
children with recurrent episodic and chronic wet cough at baseline were 
free of symptoms after a total duration of 36 months (20-54) (median, 
(quartiles)) and 33 months (17-48), respectively (Table 3).
At follow-up, more children with initially recurrent episodic wet 
cough used beta-2 agonists than children with chronic cough, and 
a similar weak tendency was seen for ICS (Table 3). During the last 
12 months before follow-up, 31.4% and 23.6% of all children re-
ported use of beta-2 agonists or ICS, respectively, whereas only 9.7% 
of all children had been given antibiotics during the last 12 months.
In children who were considered as possible PBB and prescribed 
antibiotics at the outpatient visits, 41 (67.2%) were symptom-free at 
follow-up, 15 (24.6%) had mild symptoms, 5 (8.2%) had severe symp-
toms, and 11 (18.0%) had been using ICS during the last 12 months 
before follow-up.
In children who were considered as possible asthma and pre-
scribed ICS at the outpatient visits, 62 (45.6%) were symptom-free 
at follow-up, 58 (42.6%) had mild symptoms, 16 (11.8%) had se-
vere symptoms, and 50 (36.8%) had been using ICS during the last 
12 months before follow-up.
3.2 | Risk factors for persistence of symptoms
Table 4 shows the results of regression analyses of possible risk fac-
tors for persistent airway symptoms at follow-up. None of the risk 
factors included in the analyses were associated with persistent 
symptoms.
4  | DISCUSSION
The main result of this study was the long-term outcome for chil-
dren under three years of age with recurrent episodic or chronic 
wet cough. At around seven years of age, slightly more than half of 
TA B L E  3   Symptoms during the last six months and treatment during the last 12 months before follow-up in 291 children initially referred 
to a pulmonary outpatient clinic for recurrent episodic or chronic wet cough. All children were under three years of age at the first visit to 
the paediatric outpatient clinic
 N/Total N (%)
Recurrent episodic cough 
N (%)
Chronic wet cough 
N (%) P values a 
All children 291 171/291 (58.8) 120/291 (41.2)  
Age at follow-up; months; median (quartiles) 291 84 (71, 99) 81 (61, 92) .021
No symptoms the last six months before 
follow-up
166/291 (57.0) 98/171 (57.3) 68/120 (56.7) .571b 
Mild symptoms the last six months before 
follow-up
93/291 (32.0) 57/171 (33.3) 36/120 (30.0) .571b 
Wheeze 68/290 (23.4) 43/171 (25.1) 25/119 (21.0) .413
Cough 69/290 (23.8) 42/171 (24.6) 27/119 (22.7) .713
Severe symptoms the last six months before 
follow-up
32/291 (11.0) 16/171 (9.4) 16/120 (13.3) .571b 
Wheeze 30/290 (10.3) 15/171 (8.8) 15/119 (12.6) .292
Cough 30/290 (10.3) 15/171 (8.8) 15/119 (12.6) .292
Treatment the last 12 mo before follow-up
No treatment 179/291 (61.5) 98/171 (57.3) 81/120 (67.5) .079
Any treatment 112/291 (38.5) 73/171 (42.7) 39/120 (32.5) .079
Beta-2 agonist 89/283 (31.4) 62/168 (36.9) 27/115 (23.5) .017
ICS 64/271 (23.6) 43/158 (27.2) 21/113 (18.6) .099
Leukotrienantagonist 7/250 (2.8) 7/145 (4.8) 0/105 (0) .022
Antibiotics 26/268 (9.7) 15/157 (9.6) 11/111 (9.9) .923
Duration of symptoms in the symptom-free 
group; months; median (quartiles)
159/291 (54.6) 36 (20, 54) 33 (17, 48) .208
Age of resolution in the symptom-free 
group; months; median (quartiles)
159/291 (54.6) 44 (30, 63) 39 (23, 54) .133
Note: Continuous variables were reported as medians and quartiles, dichotomous variables were reported as number and %.The denominator 
represents the number with available data.
Abbreviations: Beta-2 agonist, inhaled short-acting beta-2 agonist; ICS: inhaled corticosteroids in any combination.
aP values from Pearson's chi-square test for dichotomous variables or Mann-Whitney U test for continuous variables, except those marked b. 
Bold values represent p values under the significance level set to 0.05.
bP values from linear-by-linear association test. 
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the children were symptom-free, and only 11% had more than mild 
symptoms.
Few other studies have evaluated the long-term outcome in chil-
dren with wet cough.18 Wurzel et al followed 106 children with PBB 
for two years and found that almost one half had ongoing recurrent 
episodes with PBB and one in ten were diagnosed with bronchiecta-
sis.19 However, these were highly selected patients from a tertiary 
centre with a definite diagnosis of PBB. Two other small retrospective 
studies of children diagnosed with PBB showed that a substantial pro-
portion of these had recurrent symptoms during the next years.20,21 
We are not aware of other studies evaluating the long-term outcome 
of an unselected population of children with wet cough.
Short episodes of wet cough are common during airway infec-
tions in early childhood. The children included in this study were 
referred to a paediatric department after a long period of several 
months with recurrent episodic or chronic wet cough, thus proba-
bly representing the severe end of the spectrum of young children 
with wet cough. The proportion of children with symptoms at fol-
low-up was similar for those with initially chronic wet cough and 
for those with recurrent episodic wet cough. More children with 
recurrent episodic wet cough used asthma medication at follow-up. 
Approximately one in three children had used some asthma medi-
cation, and one in four children had been prescribed ICS during the 
last 12 months.
Chronic or recurrent episodes with cough or wheeze during early 
childhood are commonly considered as asthma, and beta-2 agonists 
and/or ICS are often prescribed.15 A high proportion of the children 
in our study had been prescribed ICS before the first outpatient visit 
or had been referred for an evaluation for possible asthma (data not 
shown). Approximately 50% of the children continued with or were 
prescribed ICS at the initial visit. This is a high number, considering 
that asthma guidelines for young children underline that wheez-
ing episodes are the dominating symptom of asthma, and cough 
without wheezing episodes should normally not be considered as 
asthma.22 A substantial proportion of the children included in the 
study were examined by young residents at our department and not 
paediatric pulmonologists, which could influence the adherence to 
asthma guidelines. More children with episodic cough had additional 
wheeze, which may explain why more of these children had been 
prescribed beta-2 agonists and the tendency for more prescription 
of ICS the last 12 months before follow-up. The use of ICS may be 
considered as an indicator of asthma, but studies have shown that 
in preschool children, the use of ICS as a marker of asthma may be 
questionable.13 Moreover, both children with tracheobronchomala-
cia and PBB may have wheezing as one of the symptoms.23,24 To 
estimate the true proportion of children with asthma at follow-up, 
one would need a thorough clinical examination including objective 
testing according to current guidelines.22
Guidelines and reviews from the last few years suggest that PBB 
is the most common cause of chronic wet cough in preschool chil-
dren.18 This diagnosis is based on wet cough lasting for more than 
four or eight weeks and a clear response to appropriate antibiotics. A 
third of the children with chronic wet cough in our study were given 
antibiotics at the first consultation. Our department has been in-
creasingly aware of the diagnosis of PBB during the study period and 
after, and probably, a higher proportion of children with chronic wet 
cough are now given antibiotics. Therefore, we do not know how 
many of the children with chronic cough actually had PBB, but over-
all, the group with chronic wet cough had a rather favourable prog-
nosis, with only 11% having more than mild symptoms at follow-up, 
and more than half of the children had no symptoms. Moreover, 
only one in ten children had been given antibiotics during the last 
six months. Therefore, the results suggest that for children with long 
standing chronic wet cough in early childhood, with or without PBB, 
the long-term prognosis is fairly good.
The regression analyses did not reveal any significant risk factor 
for the persistence of symptoms at follow-up. One possible implica-
tion from this could be that a more thorough diagnostic work up may 
be necessary at the initial visit to identify children with a higher risk 
for persistent symptoms.
The major strengths of this study were the population-based 
design and the follow-up over a long period of time. The major 
TA B L E  4   Risk factors for persistent symptoms at follow-up, 
results from unadjusted logistic regression analyses in children 
referred to a paediatric outpatient clinic under three years of age 
for recurrent episodic or chronic wet cough
Risk factors
Unadjusted models
N OR 95% CI P values
Male gender 291 0.88 0.55,1.41 .599
Prematurity (32-
37 wk of gestation)
203 2.31 0.90,5.94 .081
Parental asthma or 
atopy
248 1.25 0.72,2.17 .431
Siblings with asthma 
or atopy
153 1.56 0.83,2.96 .170
Household smoking 111 1.37 0.58,3.24 .471
Pets at home 94 0.64 0.28,1.46 .290
Age at start of 
symptoms (months)
291 1.00 0.97,1.04 .814




291 1.28 0.76,2.16 .351
Positive chest X-ray 239 0.92 0.54,1.56 .747
tPTEF/tE ratioa  232 0.99 0.97,1.01 .481
Atopy 62 0.49 0.16,1.47 .203
Episodic cough 291 0.97 0.61,1.56 .913
History of wheezing 
episodes
291 1.10 0.69,1.77 .684
Note: As no variables were significant risk factors, a fully adjusted 
model was not included.
Abbreviations: OR: odds ratio, CI: confidence interval.
aLung function was measured by tidal breathing and was reported as 
the ratio of time to reach peak tidal expiratory flow to total expiratory 
time (tPTEF/tE). 
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weakness was the retrospective design with the probability of re-
call bias, especially in children who have been symptom-free for a 
long time, and that symptom registration was only based on parental 
recall. Children were not systematically followed at the outpatient 
clinic until resolution of symptoms or a final diagnosis was given. 
Moreover, the rather low participation rate may have given a selec-
tion bias, with non-responders being different from responders. It is 
possible that more parents of symptomatic children have responded, 
and consequently, the outcome for the whole group may be more 
favourable than we have shown.
5  | CONCLUSION
In conclusion, we have shown that approximately half of the chil-
dren presenting with severe chronic or recurrent episodic wet cough 
during early childhood have a good prognosis, but for some chil-
dren, these symptoms may be early signs of persistent symptoms 
or disease. Improved care for these children may include regular 
follow-ups until resolution of symptoms or until a specific diagnosis 
is found, and appropriate treatment is established.
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